During an inspection on November 20, 2024, the Food and Drug Administration (FDA) issued two citations to Stridelink, Inc. in Atlanta related to device compliance, according to data posted on the FDA’s website.
The FDA website indicates that the citations were delivered to the company as follows:
- ‘There is no agreement with suppliers to notify you of changes in the product or service.’
- ‘Acceptance activities were not adequately documented.’
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
